Mobile Site ›

Free Light Chains & Monoclonal Gammopathies

Impact on Diagnostic Panels

Plasma Cell Proliferative Disorders

Slide 4

August 2008

The testing we’re talking about are tests to indentify virtually all of these plasma cell proliferative disorders by indentifying the presence of monoclonal gammopathy. That is, diagnosing a monoclonal immunoglobulin. In addition to diagnostic uses PEL, IFE and free light chain assays may be useful for prognosis of either progression or survival and also may be used for disease monitoring.

Plasma Cell Proliferative Disorders


Jump to section: